HCP Live February 12, 2024
The prominent clinical investigator joins to discuss adjuvant and neoadjuvant care research, as well as the application of biomarkers in personalized care.
As lung cancer prevalence and mortality continues to burden an aging North American population, the strategies to apply the right care to the right patient at the right time is becoming increasingly refined. Precision medicine, a catch-all term for the pursuit of clinical and demographic-tailored treatment, is becoming a more tangible pursuit as researchers uncover intricate details on their care regimens over time.
In later-stage lung cancer, understanding the utility of neoadjuvant, perioperative and adjuvant therapy relevant to invasive care in the right patient could make all the difference.
In the latest episode of Lungcast, an increasingly...
Today's Sponsors
Today's Sponsor